Key result
Enteral glucose or fructose coinfused with Intralipid significantly stimulated intestinal TRL-apoB48 production compared with Intralipid alone (P<0.01 for glucose, P<0.05 for fructose).
Why the study?
Does enteral glucose or fructose co-infused with lipid increase intestinal triglyceride-rich lipoprotein particle production in healthy humans?
RCT (n=14)
Does enteral glucose or fructose co-infused with lipid increase intestinal triglyceride-rich lipoprotein particle production in healthy humans?
p-value: p=<0.01
Enteral monosaccharides (glucose and fructose) acutely enhance intestinal lipoprotein particle production when co-administered with lipids, which may aggravate hyperlipidemia.
May worsen postprandial lipemia with mixed meals; extends intestinal TRL regulation mechanisms in healthy humans.
OBJECTIVE: Overproduction of triglyceride-rich lipoproteins (TRLs) by liver and intestine contributes to hypertriglyceridemia and may increase cardiovascular risk. Dietary carbohydrates, especially fructose, have been shown to amplify postprandial lipemia but little is known about its effect on intestinal TRL particle production. Here, we examined intestinal and hepatic TRL particle production in response to enteral glucose or fructose in the presence of enteral lipid. APPROACH AND RESULTS: In 2 randomized studies, 4 to 6 weeks apart, 7 healthy male subjects received intraduodenal infusion of Intralipid plus saline or glucose. TRL-apolipoprotein (apo) B48 and apoB100 kinetics were assessed under pancreatic clamp conditions. In a separate study of another 7 subjects under similar conditions, glucose was replaced by fructose. When coinfused with Intralipid into the duodenum, glucose markedly stimulated TRL-apoB48 production (P<0.01), with a concomitant moderate increase in fractional clearance (P<0.05), resulting in net elevation of TRL-apoB48 concentration. TRL-apoB100 concentration, fractional clearance, and production were not significantly affected by glucose. When glucose was replaced by fructose, both TRL-apoB100 and apoB48 production (P<0.05), but not fractional clearance, were enhanced compared with Intralipid alone. CONCLUSIONS: These results reveal a novel role of monosaccharides in acutely enhancing intestinal lipoprotein particle production, thereby aggravating hyperlipidemia.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2013) conducted an RCT in Healthy (n=14). Intraduodenal infusion of Intralipid plus glucose or fructose vs. Intralipid plus saline (Intralipid alone) was evaluated on TRL-apoB48 and apoB100 production (p=<0.01). Enteral glucose or fructose coinfused with Intralipid significantly stimulated intestinal TRL-apoB48 production compared with Intralipid alone (P<0.01 for glucose, P<0.05 for fructose).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: